HIV in Europe 2020 – what will it look like? | Carlo Federico Perno, MD, PhD

European Meeting on HIV & Hepatitis 2016

Viral Dynamics During Suppressive ART - Towards HIV-1 Elimination From Reservoirs - Thomas Klimkait

European Meeting on HIV & Hepatitis 2019

Association of alcohol use with HIV among men & women in Hoima district, Mid-Western Uganda

INTEREST 2020

Toxicity-adjusted dose (TAD) of sunitinib - H. Gurney

International Workshop on Dose Optimization Strategies for Targeted Drugs – Focus on Oncolytics 2015

Richard Elion | Long-Acting Drugs for PrEP

Rio de Janeiro HIV Clinical Forum 2020

Towards an HIV Cure; clinical strategies and trials | Jintanat Ananworanich, MD, PhD

APACC 2016

Assessing the Cost-Effectiveness of a Treat-All Policy Change for Hepatitis B in Six Who Regions | Christopher Seaman

International Viral Hepatitis Elimination Meeting (IVHEM) 2023

Prognosis of HIV-positive children receiving ART: an 18-year retrospective study in Chokwe, Mozambique

International Workshop on HIV & Adolescence 2021

Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients- M. Van Dijk

International Viral Hepatitis Elimination Meeting (IVHEM) 2019

An Assessment in Hanoi, Vietnam: City-wide Training Targeting Understanding and Trust Improved Undetectable=Untransmittable Message Delivery Among Healthcare Workers

APACC 2020